发明名称 Biologically active tgf-beta 1 and tgf-beta 2 peptides
摘要 The invention relates to peptides corresponding to regions of the amino acid sequence of TGF- beta 1 or TGF- beta 2 which retain, either in monomeric or polymeric forms, at least some of the biological activity of the respective full length TGF- beta . The monomeric form of the peptide derived from TGF- beta 1 comprises the following amino acid sequence: CVRQLYIDFRKDLGWKWIHEPKGYHANFCLGP (SEQ ID NO: 1). The monomeric form of the peptide derived from TGF- beta 2 comprises the following amino acid sequence: CLRPLYIDFKRDLGWKWIHEPKGYNANFCAGA (SEQ ID NO: 2). Dimers may be formed via disulfide bonds between the amino-terminal cysteine residues, the carboxy-terminal cysteine residues, or amino- and carboxy-terminal cysteine residues of the monomer subunits.
申请公布号 AU6093294(A) 申请公布日期 1994.08.15
申请号 AU19940060932 申请日期 1994.01.21
申请人 CELTRIX PHARMACEUTICALS, INC. 发明人 YASUSHI OGAWA;DAVID SCHMIDT
分类号 A61K38/22;A61K38/00;A61P19/00;A61P29/00;A61P43/00;C07K14/495 主分类号 A61K38/22
代理机构 代理人
主权项
地址